(PD-1) antibody. In some embodiments, this invention relates to methods for treating Hodgkin's lymphoma in a subject comprising administering to the subject a combination of an anti-cancer agent which is an anti-Programmed Death-1 (PD-1) antibody and another anti-cancer agent such as an ...
Hodgkin lymphoma If you've formed mutant cells called Reed-Sternberg cells, your doctor will diagnose you with Hodgkin lymphoma. There are two main types: classical and nodular lymphocyte predominant. Cancer treatments such as chemotherapy can cure many people with this type of lymphoma. And if it...
Hodgkin lymphoma If you've formed mutant cells called Reed-Sternberg cells, your doctor will diagnose you with Hodgkin lymphoma. There are two main types: classical and nodular lymphocyte predominant. Cancer treatments such as chemotherapy can cure many people with this type of lymphoma. And if it...
The treatment of classical Hodgkin lymphoma (cHL) in children is a story of success. Nowadays, more than 90% of patients are cured and overall survival is nearly 100% at 5years. Efforts have been made to avoid related effects of therapies; therefore, children are treated using different ...
Wilmington, Delaware, United States, Transparency Market Research Inc. – Hodgkin Lymphoma is a cancer of the lymphatic system known as lymphoma part of the immune system.
This review discusses current trends in the treatment of Hodgkin lymphoma, focusing on optimizing therapy outcomes while minimizing toxicity. We summarize advances made by the incorporation of Brentuximab Vedotin into first line therapy for advanced stage Hodgkin lymphoma. Similarly, the incorporation of ...
Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy... Between 1983 and 1987 the Radiation Therapy Oncology Group conducted a prospective phase II study to evaluate survival in primary non-...
The successful treatment of Hodgkin's lymphoma is one of the most impressive achievements of modern medicine. Today more than 90 % of patients without fever, weight loss, or night sweats (B symptoms) are cured with optimal treatment, and 60–70 % of those with B symptoms are cured as ...
The objective of this study is to present a patient with hypopharyngeal epithelioid malignant schwannoma as a secondary malignant neoplasm following treatment with MOPP and radiotherapy. The patient, presently a 43 year-old man, was diagnosed at clinical stage III Hodgkin's lymphoma (HL) with mixed...
Treatment of non-Hodgkin's lymphoma: a look over the past decade. The past decade has seen enormous changes in our understanding of lymphomas with a better classification (World Heath Organization) and identification of b... B Coiffier - 《Clinical Lymphoma & Myeloma》 被引量: 144发表: 2006...